Evid Invest
Who owns CLDXWhat CLDX owns — n/a

Who owns Celldex Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of CLDX from SEC Form 13F filings across 250 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 250 institutions disclosed 89.6M shares of Celldex Therapeutics, Inc. worth $2.90B — about 114% of shares outstanding; the largest disclosed holder is WELLINGTON MANAGEMENT GROUP LLP. Source: SEC Form 13F filings, parsed by EvidInvest.

250

13F holders

$2.90B

value, 2026 filers

114%

of shares outstanding (89.6M sh)

40

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CLDX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1WELLINGTON MANAGEMENT GROUP LLP10.7M$345.9M0.1%13.6%+11.8%
2FMR LLC8.6M$279.9M0.0%11%+132.0%
3BlackRock, Inc.6.9M$225.2M0.0%8.8%-0.8%
4Kynam Capital Management, LP5.1M$164.2M9.1%6.5%-4.8%
5PRICE T ROWE ASSOCIATES INC /MD/4.4M$142.1M0.0%5.6%-6.4%
6STATE STREET CORP3.5M$112.7M0.0%4.4%-10.8%
7VANGUARD CAPITAL MANAGEMENT LLC3.5M$112.7M0.0%4.4%+0.3%
8BAKER BROS. ADVISORS LP2.6M$83.1M0.4%3.3%+116.9%
9Deep Track Capital, LP2.1M$68.9M1.1%2.7%-27.7%
10GEODE CAPITAL MANAGEMENT, LLC2.0M$66.4M0.0%2.6%+1.3%
11EVENTIDE ASSET MANAGEMENT, LLC1.9M$61.5M0.9%2.4%+82.9%
12GOLDMAN SACHS GROUP INC1.6M$52.5M0.0%2.1%+0.2%
13Driehaus Capital Management LLC1.4M$45.3M0.3%1.8%+41.3%
14Fisher Asset Management, LLC1.2M$40.4M0.0%1.6%+26.5%
15Eversept Partners, LP1.2M$38.1M2.0%1.5%-34.2%
16Affinity Asset Advisors, LLC1.2M$37.6M1.5%1.5%+65.8%
17DIMENSIONAL FUND ADVISORS LP1.1M$37.2M0.0%1.5%+6.9%
18Elmind Capital, LP1.1M$36.0M8.9%1.4%+12.1%
19FEDERATED HERMES, INC.1.0M$34.0M0.0%1.3%+113.0%
20AMERICAN CENTURY COMPANIES INC1.0M$33.9M0.0%1.3%+0.3%
21Commodore Capital LP1.0M$32.4M2.5%1.3%-25.9%
22NOVO HOLDINGS A/S950,000$30.8M2.1%1.2%-7.3%
23UBS Group AG929,277$30.1M0.0%1.2%+92.8%
24VANGUARD PORTFOLIO MANAGEMENT LLC906,135$29.4M0.0%1.2%+4.9%
25Frazier Life Sciences Management, L.P.NEW900,080$29.2M0.7%1.1%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.